Emma Cracknell | FleishmanHillard in the European Union

Emma leads FH Brussels’ healthcare team, specifically focusing on strategically advising clients on the development and execution of EU Public Affairs strategies, and European market level public affairs plans for pharmaceutical companies ahead of product launch. Prior to joining FH in 2015, Emma completed GSK’s Communications and Government Relations Future Leader’s Programme, with placements in the Pharmaceutical and Consumer Health businesses in London, UK and Vaccines in Wavre, Belgium. A native English speaker, Emma also has working proficiency in French.

Posts by Emma Cracknell

Why are the French the most skeptical about COVID-19 vaccines in the EU?

April 7, 2021
Vaccine hesitancy and conspiracy mentalities in German: a deadly duo?

April 1, 2021
Regional approaches and shared competences, the kryptonite for anti-vaxxers in Spain?

March 30, 2021
2021 – the year of the vaccine

January 12, 2021
Launching FH Brussels’ Recovery and Resurgence COVID-19 Practice

June 3, 2020
The Impact of COVID-19 on Innovation for Pharma Companies

April 10, 2020
What does the future (Commission) hold for access to medicines?

September 28, 2018
What If - The Impact of the UK Referendum on EU Membership on the Council and European Parliament

June 23, 2016